The present invention relates to compounds (1) that bind to the NR1H4 receptor (FXR) and act as FXR agonists. The invention further relates to the use of the compounds (1) for the preparation of a medicament for the treatment of diseases and / or conditions by means of the binding of said nuclear receptor to said compounds, and to a method for the synthesis of said compounds. . (see Formula).